CIK 0001645469
- Non-accelerated filer
- Smaller reporting company
Monopar Therapeutics
Sign in to watch- Ticker
- MNPR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 320463781
- Phone
- +1 847-388-0349
- Business address
- 1000 SKOKIE BLVD SUITE 350, WILMETTE, IL, 60091
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,335,315
- in 9 filings, $5.3M under 10b5-1 plans
Net −$5,335,315. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-12-30 | RIOUX PATRICE Acting Chief Medical Officer | Grant or award · Stock option | +20,000 | 20,000 | ||
| 2018-08-28 | Tsuchimoto Kim R Chief Financial Officer | Grant or award · Stock options | +41,100 | 41,100 | ||
| 2018-08-28 | Tsuchimoto Kim R Chief Financial Officer | Grant or award · Stock options | +41,100 | 85,620 | ||
| 2018-08-09 | Anderson Raymond Director | Grant or award · Stock options | +26,100 | 26,100 | ||
| 2018-08-09 | Brown Michael J Director | Grant or award · Stock options | +26,100 | 26,100 | ||
| 2018-08-09 | KLAUSNER ARTHUR J Director | Grant or award · Stock options | +26,100 | 26,100 | ||
| 2018-08-09 | STARR CHRISTOPHER M Director | Grant or award · Stock options | +26,100 | 26,100 | ||
| 2018-08-09 | Robinson Chandler Chief Executive Officer | Grant or award · Stock options | +145,500 | 145,500 | ||
| 2018-08-09 | Mazar Andrew Paul Chief Scientific Officer | Grant or award · Stock options | +134,300 | 134,300 |
Page 28 of 28 · 549 trades